US FDA warns of serious risks with psoriasis drug Raptiva®

被引：0

|

作者：

不详

机构：

来源：

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2009年 / 7卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：393 / 394

页数：2

相关论文

共 50 条

[1] US FDA warns of serious risks with psoriasis drug Raptiva®
不详
[J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2009, 5 (03) : 229 - 229
[2] FDA Warns of Risks of Body Sculpting
Rubin, Rita
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (03): : 201 - 201
[3] FDA Warns of Risks Related to Epidural Injections
Kuehn, Bridget M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (20): : 2057 - 2057
[4] FDA warns about heartburn drug
Josefson, D
[J]. BRITISH MEDICAL JOURNAL, 1998, 317 (7151): : 101 - 101
[5] Rituxan associated with PML, warns US FDA
[J]. Reactions Weekly, 2007, 1133 (1) : 3 - 3
[6] US FDA warns of hypericum/indinavir interaction
[J]. Reactions Weekly, 2000, 789 (1) : 2 - 2
[7] FDA warns of serious prostate cancer with 5-αRIs
[J]. Reactions Weekly, 2011, 1356 (1) : 3 - 3
[8] FDA warns of serious harm from IV administration of nimodipine
[J]. Reactions Weekly, 2010, 1313 (1) : 4 - 4
[9] Propylthiouracil may cause serious liver injury, warns FDA
[J]. Reactions Weekly, 2009, 1256 (1) : 2 - 2
[10] FDA warns against Lyme disease drug
Fox, Steven
[J]. INFECTIONS IN MEDICINE, 2006, 23 (09) : 398 - 398

← 1 2 3 4 5 →